Impact of duration and dosage of statin treatment and epicardial fat thickness on the recurrence of atrial fibrillation after electrical cardioversion
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of duration and dosage of statin treatment and epicardial fat thickness on the recurrence of atrial fibrillation after electrical cardioversion
Authors
Keywords
Statin, Atrial fibrillation, Electrical cardioversion, Epicardial fat thickness
Journal
HEART AND VESSELS
Volume 30, Issue 4, Pages 490-497
Publisher
Springer Nature
Online
2014-04-01
DOI
10.1007/s00380-014-0505-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin Use and Risk of Atrial Fibrillation or Flutter
- (2015) Giacomo Veronese et al. AMERICAN JOURNAL OF THERAPEUTICS
- New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio
- (2013) Halit Acet et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Epicardial Adipose Tissue Thickness and Ablation Outcome of Atrial Fibrillation
- (2013) Tze-Fan Chao et al. PLoS One
- The Impacts of C-Reactive Protein and Atrial Fibrillation on Carotid Atherosclerosis and Ischemic Stroke in Patients with Suspected Ischemic Cerebrovascular Disease: A Single-Center Retrospective Observational Cohort Study
- (2013) So Young Ock et al. Korean Circulation Journal
- Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis
- (2012) Lorenzo Loffredo et al. BMC Cardiovascular Disorders
- Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation
- (2012) Meytal Avgil Tsadok et al. CIRCULATION
- Effects of Statin Therapy on the Production of Monocyte Pro-Inflammatory Cytokines, Cardiac Function, and Long-Term Prognosis in Chronic Heart Failure Patients With Dyslipidemia
- (2012) Akihiro Nakagomi et al. CIRCULATION JOURNAL
- Association Between Lipid Profile and Risk of Atrial Fibrillation
- (2011) Hiroshi Watanabe et al. CIRCULATION JOURNAL
- Hypercholesterolemia Induces Up-regulation of KAChCardiac Currents via a Mechanism Independent of Phosphatidylinositol 4,5-Bisphosphate and Gβγ
- (2011) Wu Deng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
- (2011) Valentin Fuster et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Atorvastatin Given prior to Electrical Cardioversion Does Not Affect the Recurrence of Atrial Fibrillation in Patients with Persistent Atrial Fibrillation Who Are on Antiarrhythmic Therapy
- (2011) Kenan Demir et al. MEDICAL PRINCIPLES AND PRACTICE
- Lack of effect of statins on maintenance of normal sinus rhythm following electrical cardioversion of persistent atrial fibrillation
- (2010) A. Bhardwaj et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Increasing Prevalence of Atrial Fibrillation and Flutter in the United States
- (2009) Gerald V. Naccarelli et al. AMERICAN JOURNAL OF CARDIOLOGY
- Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
- (2009) L. Julian Haywood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Rosuvastatin on Asymmetric Dimethylarginine Levels and Early Atrial Fibrillation Recurrence after Electrical Cardioversion
- (2009) WEI XIA et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Electrical and Pharmacologic Cardioversion for Atrial Fibrillation
- (2008) Susan S. Kim et al. CARDIOLOGY CLINICS
- Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation
- (2008) Laurent Fauchier et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started